| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 115,468 | $28.68 | $3,311,125.73 | -70.5% | +10.3% | - | |
| Nov 26, 2025 | Mignone Roberto | Director | Sell | 50,000 | $26.03 | $1,301,505.00 | -10.1% | +28.9% | - | |
| Nov 20, 2025 | Fox Christine | EVP, Head Of U.s. Commercial | Sale+OE | 28,229 | $24.78 | $699,523.09 | -30.7% | +40.5% | - | |
| Nov 14, 2025 | Fox Christine | EVP, Head Of U.s. Commercial | Sell | 30,000 | $25.11 | $753,321.00 | -51.4% | +33.5% | - | |
| Nov 6, 2025 | Weiss Amir | Chief Accounting Officer | Sell | 12,300 | $24.44 | $300,564.03 | -40.7% | +42.9% | - | |
| Nov 6, 2025 | Mignone Roberto | Director | Sell | 200,000 | $24.11 | $4,821,880.00 | -28.8% | +42.9% | - | |
| Sep 5, 2025 | McAvoy David R. | EVP, Chief Legal Officer | Buy | 1,113 | $18.86 | $20,988.06 | +9.3% | +49.9% | - | |
| Aug 1, 2025 | Hughes Eric A | See "remarks" | Sale+OE | 52,742 | $15.16 | $799,436.87 | -100% | +30.2% | +125.7% | |
| Aug 1, 2025 | Jover Placid | See "remarks" | Sale+OE | 6,053 | $15.16 | $91,748.35 | -47.2% | +30.2% | +125.7% | |
| Jun 12, 2025 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 55,775 | $17.08 | $952,464.10 | -12.1% | +10.5% | - |